跳至主要内容
临床试验/NCT06112093
NCT06112093招募中1 期

Using Repetitive Transcranial Magnetic Stimulation to Manage Headaches and Improve Rehabilitation Outcomes in Mild Traumatic Brain Injury: A Longitudinal Study

State University of New York - Upstate Medical University2 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2023年10月23日最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
招募中
发起方
入组人数
60
试验地点
2
主要终点
Gene expression

研究概览

简要总结

This study aims to examine the long-term effect of repetitive transcranial magnetic stimulation (rTMS), a non-invasive brain stimulation technique, on chronic headaches following mild traumatic brain injury (mTBI). rTMS has been shown to be effective in reducing chronic headaches without side effects commonly seen in medications, such as sleepiness and addiction. This study uses rTMS to manage chronic headaches to improve post-concussion symptoms and reduce the economic burden due to delayed recovery. This project aims to better identify biomarkers for diagnosis and prognosis and maximize recovery from mTBI.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 55 Years(Adult)
性别
All
接受健康志愿者
是

入选标准

  • •18 - 55 years old
  • •mTBI with loss of consciousness for less than 30 min, initial Glasgow Coma Scale between 13 and 15, or post-traumatic amnesia for ≤ 24 hours
  • •diagnosis of persistent post-traumatic headache according to the International Classification of Headache Disorders, 3rd edition (ICHD-3) criteria
  • •headache develops within 7 days after head trauma
  • •headache persists for >=3 months after head trauma despite receiving standard care
  • •average persistent headache intensity is >= 3/10 of the numerical rating scale (NRS) on >=3days/week
  • •no evidence of radiculopathy or peripheral neuropathy on electromyography or clinical evaluation
  • •no evidence of other possible causes of headaches

排除标准

  • •history of chronic headache diagnoses such as migraine, tension, or cluster headaches prior to the incidence of mTBI
  • •history of other neurologic conditions with medications affecting the central nervous system
  • •contraindications of receiving TMS (e.g., a history of epileptic seizure and having implants like a cardiac pacemaker or intracerebral vascular clip

研究组 & 干预措施

Moderate-dose rTMS

Active Comparator

12 sessions (1 session/day, 3 days/week for 4 weeks) of active rTMS

干预措施: Repetitive Transcranial Magnetic Stimulation (Device)

Sham rTMS

Sham Comparator

12 sessions (1 session/day, 3 days/week for 4 weeks) of sham rTMS will be administered at the same location and duration as the Moderate-rTMS protocol. After the study is completed, participants will be offered an opportunity to receive active rTMS.

干预措施: Sham Repetitive Transcranial Magnetic Stimulation (Device)

High-dose rTMS

Active Comparator

24 sessions (4 sessions/day, 3 days/week for 2 weeks) of active rTMS

干预措施: Repetitive Transcranial Magnetic Stimulation (Device)

Low-dose rTMS

Active Comparator

6 sessions (1 session/day, 3 days/week for 2 weeks) of active rTMS

干预措施: Repetitive Transcranial Magnetic Stimulation (Device)

结局指标

主要结局

Gene expression

时间窗: baseline, immediately post-treatment (completion of rTMS)

Peripheral blood will be collected to measure mRNA to impute gene expression.

Headache impact test 6 (HIT-6)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The HIT-6 will be used to assess the impact of headaches on one's ability to function in occupational and social lives. On a scale of 36 to 78, higher numbers indicate worse outcomes.

Post-Concussion Symptom Scale (PCSS)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The change in global post-concussion symptoms will be measured by the PCSS. On a scale of 1 to 5, higher numbers indicate worse outcomes.

Daily headache diary

时间窗: daily documentation throughout the treatment course (4 weeks)

Composite headache score will be calculated as average intensity (NRS) × average frequency (episode/day) × average duration (hours/episode).

Patient-Reported Outcomes Measurement Information System (PROMIS)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The PROMIS questionnaires with subsections of 1) pain interference, 2) pain behavior will be used as patient-reported outcomes of pain and sleep. For all subsections, on a scale of 1 to 5, higher numbers indicate worse outcomes.

Wrist actigraphy - physical activity level

时间窗: baseline, immediately post-treatment (completion of rTMS)

Kinematic assessments by the wrist actigraphy will be worn to measure physical activity level.

Neurophysiological measures by TMS

时间窗: baseline, immediately post-treatment (completion of rTMS)

Neurophysiology will be measured by TMS to indicate changes in brain function.

Daily headache diary

时间窗: daily documentation throughout the treatment course (4 weeks)

Composite headache score will be calculated as average intensity (NRS) × average frequency (episode/day) × average duration (hours/episode).

Patient-Reported Outcomes Measurement Information System (PROMIS)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The PROMIS questionnaires with subsections of 1) pain interference, 2) pain behavior will be used as patient-reported outcomes of pain and sleep. For all subsections, on a scale of 1 to 5, higher numbers indicate worse outcomes.

Protein expression

时间窗: baseline, immediately post-treatment (completion of rTMS)

Peripheral blood will be collected to measure protein expression

Neurophysiological measures by TMS

时间窗: baseline, immediately post-treatment (completion of rTMS)

Neurophysiology will be measured by TMS to indicate changes in brain function.

Headache impact test 6 (HIT-6)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The HIT-6 will be used to assess the impact of headaches on one's ability to function in occupational and social lives. On a scale of 36 to 78, higher numbers indicate worse outcomes.

Post-Concussion Symptom Scale (PCSS)

时间窗: baseline, immediately post-treatment (completion of rTMS), 1-month follow-up, 3-month follow-up, 6-month follow-up

The change in global post-concussion symptoms will be measured by the PCSS. On a scale of 1 to 5, higher numbers indicate worse outcomes.

Wrist actigraphy - physical activity level

时间窗: baseline, immediately post-treatment (completion of rTMS)

Kinematic assessments by the wrist actigraphy will be worn to measure physical activity level.

Gene expression

时间窗: baseline, immediately post-treatment (completion of rTMS)

Peripheral blood will be collected to measure mRNA to impute gene expression.

次要结局

  • Wrist actigraphy - sleep quality(baseline, immediately post-treatment (completion of rTMS))

研究者

发起方
State University of New York - Upstate Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Yi-Ling Kuo, PT, PhD

Assistant Professor

State University of New York - Upstate Medical University

研究点 (2)

Loading locations...

相似试验

Repetitive Transcranial Magnetic Stimulation for... | 临床试验